# Varenicline Treatment for Active Alcoholic Smokers

> **NCT01347112** · PHASE2,PHASE3 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 33 (actual)

## Conditions studied

- Smoking
- Tobacco Dependence
- Alcohol Dependence

## Interventions

- **DRUG:** Varenicline
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01347112
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2014-01
- **Final completion:** 2014-03
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2018-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01347112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01347112, "Varenicline Treatment for Active Alcoholic Smokers". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01347112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*